Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CHE compared with HALO: revenue, margins and what each company keeps, and the suppliers and customers both name
CHE
Chemed Corp
Change
Mkt cap
Revenue
Revenue
HALO
Halozyme Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CHE
Chemed Corp
vs
HALO
Halozyme Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CHE
8
—
Covenant Health and Community Services, Inc d/b/a/ Covenant Care ("Covenant")
unlisted
supplier
—
Medicaid program
unlisted
customer
—
Medicare and Medicaid programs
unlisted
customer
—
Medicare program
unlisted
customer
4 more · CHE chain
›
Shared
0
No shared counterparties.
Only HALO
32
LLY
Eli Lilly and Company ("Lilly")
customer
ABOS
Acumen Pharmaceuticals, Inc. ("Acumen")
customer
ARGX
argenx BVBA ("argenx")
customer
SKYE
Skye Bioscience, Inc. ("Skye Bioscience")
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
customer
28 more · HALO chain
›
CHE
Chemed Corp
Change
534.36
· pre 534.73
· delayed
Mkt cap
$7.0B
Revenue
$691M
Q3 FY26
Revenue
$2.5B
FY25
HALO
Halozyme Therapeutics, Inc.
Change
130.89
· pre 130.16
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$14.9B
Revenue
$481M
Q2 FY26
Revenue
$1.4B
FY25
vs
Compare
Pre-market
Oct 30 '26
delayed
CHE
Chemed Corp
vs
HALO
Halozyme Therapeutics, Inc.
534.36
pre 534.73
delayed
Price
130.89
pre 130.16
delayed
$7.0B
Mkt cap
$14.9B
Q3 FY26
$691M
Revenue
$481M
Q2 FY26
FY25
$2.5B
Revenue
$1.4B
FY25
Change
Change
CHE
534.36
vs
HALO
130.89
Pre-market
Oct 30 '26
delayed